biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Aarcoron Sep 24, 2015 9:52am

154 Views

Post# 24131103

RE:RE:RE:someone wants this stock.........

IIRC, the idea is to keep the share price under $1.40 until commercial news arrives. Those warrant holders want the risk free exercise, not something forced on them beforehand.

At least that's another good slug of stock out of their hands, but maybe on the next placement, should it be needed, bioasis will more carefully consider who they allocate shares to.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property